-
1
-
-
1942460493
-
-
Chinese source
-
-
-
-
2
-
-
1942460491
-
-
Chinese source
-
-
-
-
3
-
-
0036174151
-
Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18
-
Lou C, Chen ZN, Bian HJ, Li J, Zhou SB. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18. World J Gastroenterol 2002;8:69-73
-
(2002)
World J Gastroenterol
, vol.8
, pp. 69-73
-
-
Lou, C.1
Chen, Z.N.2
Bian, H.J.3
Li, J.4
Zhou, S.B.5
-
4
-
-
0035034693
-
Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F(ab′) (2) fragment and staphylococcal enterotoxin A
-
Yang LJ, Sui YF, Chen ZN. Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F(ab′) (2) fragment and staphylococcal enterotoxin A. World J Gastroenterol 2001;7:216-221
-
(2001)
World J Gastroenterol
, vol.7
, pp. 216-221
-
-
Yang, L.J.1
Sui, Y.F.2
Chen, Z.N.3
-
5
-
-
0034120121
-
Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment: A radioimmunoconjugate for hepatocellular carcinoma imaging
-
Bian HJ, Chen ZN, Deng JL. Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment:a radioimmunoconjugate for hepatocellular carcinoma imaging. World J Gastroenterol 2000;6:348-352
-
(2000)
World J Gastroenterol
, vol.6
, pp. 348-352
-
-
Bian, H.J.1
Chen, Z.N.2
Deng, J.L.3
-
6
-
-
0001039055
-
99mTc-labeled HAb18 McAb Fab fragment for radioimmunoimaging in nude mice bearing human hepatocellular carcinoma
-
Qiu K, Wang BC, Chen ZN, Fang P, Liu CG, Wan WX, Liu YF. 99mTc-labeled HAb18 McAb Fab fragment for radioimmunoimaging in nude mice bearing human hepatocellular carcinoma. World J Gastroenterol 1998;4:117-1201
-
(1998)
World J Gastroenterol
, vol.4
, pp. 117-1201
-
-
Qiu, K.1
Wang, B.C.2
Chen, Z.N.3
Fang, P.4
Liu, C.G.5
Wan, W.X.6
Liu, Y.F.7
-
7
-
-
1942428659
-
-
Chinese source
-
-
-
-
8
-
-
0030610825
-
Value of HAMA - Determination in clinical practice - An overview
-
Hasholzner U, Stieber P, Meier W, Lamerz R. Value of HAMA - determination in clinical practice - an overview. Anticancer Res 1997;17:3055-3058
-
(1997)
Anticancer Res
, vol.17
, pp. 3055-3058
-
-
Hasholzner, U.1
Stieber, P.2
Meier, W.3
Lamerz, R.4
-
9
-
-
0037391745
-
Recombinant antibodies for cancer diagnosis and therapy
-
Souriau C, Hudson PJ. Recombinant antibodies for cancer diagnosis and therapy. Expert Opin Biol Ther 2003;3:305-318
-
(2003)
Expert Opin Biol Ther
, vol.3
, pp. 305-318
-
-
Souriau, C.1
Hudson, P.J.2
-
10
-
-
0036236210
-
Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3
-
He FT, Nie YZ, Chen BJ, Qiao TD, Fan DM, Li RF, Kang YS, Zhang Y. Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3. World J Gastroenterol 2002;8:258-262
-
(2002)
World J Gastroenterol
, vol.8
, pp. 258-262
-
-
He, F.T.1
Nie, Y.Z.2
Chen, B.J.3
Qiao, T.D.4
Fan, D.M.5
Li, R.F.6
Kang, Y.S.7
Zhang, Y.8
-
11
-
-
1942460490
-
-
Chinese source
-
-
-
-
12
-
-
0037615120
-
Advancing role of radiolabeled antibodies in the therapy of cancer
-
Goldenberg DM. Advancing role of radiolabeled antibodies in the therapy of cancer. Cancer Immunol Immunother 2003;52:281-296
-
(2003)
Cancer Immunol Immunother
, vol.52
, pp. 281-296
-
-
Goldenberg, D.M.1
-
13
-
-
0037615112
-
Monoclonal antibody drug immunoconjugates for targeted treatment of cancer
-
Trail PA, King HD, Dubowchik GM. Monoclonal antibody drug immunoconjugates for targeted treatment of cancer. Cancer Immunol Immunother 2003;52:328-337
-
(2003)
Cancer Immunol Immunother
, vol.52
, pp. 328-337
-
-
Trail, P.A.1
King, H.D.2
Dubowchik, G.M.3
-
14
-
-
0035988624
-
Monoclonal antibody-based therapy strategies: Providing options for the cancer patient
-
Milenic DE. Monoclonal antibody-based therapy strategies: providing options for the cancer patient. Curr Pharm Des 2002;8:1749-1764
-
(2002)
Curr Pharm Des
, vol.8
, pp. 1749-1764
-
-
Milenic, D.E.1
-
15
-
-
0035823645
-
Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: A candidate therapeutic for IDDM and SLE
-
Chuntharapai A, Lai J, Huang X, Gibbs V, Kim KJ, Presta LG, Stewart TA. Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: a candidate therapeutic for IDDM and SLE. Cytokine 2001;15:250-260
-
(2001)
Cytokine
, vol.15
, pp. 250-260
-
-
Chuntharapai, A.1
Lai, J.2
Huang, X.3
Gibbs, V.4
Kim, K.J.5
Presta, L.G.6
Stewart, T.A.7
-
16
-
-
0037235949
-
Engineered antibodies
-
Hudson PJ, Souriau C. Engineered antibodies. Nat Med 2003;9:129-134
-
(2003)
Nat Med
, vol.9
, pp. 129-134
-
-
Hudson, P.J.1
Souriau, C.2
-
17
-
-
0345701215
-
Humanization of the anti-CD18 antibody 6.7: An unexpected effect of a framework residue in binding to antigen
-
Caldas C, Coelho V, Kalil J, Moro AM, Maranhao AQ, Brigido MM. Humanization of the anti-CD18 antibody 6.7:an unexpected effect of a framework residue in binding to antigen. Mol Immunol 2003;39:941-952
-
(2003)
Mol Immunol
, vol.39
, pp. 941-952
-
-
Caldas, C.1
Coelho, V.2
Kalil, J.3
Moro, A.M.4
Maranhao, A.Q.5
Brigido, M.M.6
-
18
-
-
0035524114
-
Improving the efficacy of antibody-based cancer therapies
-
Carter P. Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001;1:118-129
-
(2001)
Nat Rev Cancer
, vol.1
, pp. 118-129
-
-
Carter, P.1
-
20
-
-
3042777562
-
Platelet glycoprotein IIb/IIIa inhibitors
-
Hellstrom HR. Platelet glycoprotein IIb/IIIa inhibitors. Circulation 2003;107:E39-49
-
(2003)
Circulation
, vol.107
-
-
Hellstrom, H.R.1
-
21
-
-
1942524935
-
-
Chinese source
-
-
-
-
22
-
-
0032144271
-
F (ab′)2 molecules made from Escherichia coli produced Fab′ with hinge sequences conferring increased serum survival in an animal model
-
Humphreys DP, Vetterlein OM, Chapman AP, King DJ, Antoniw P, Suitters AJ, Reeks DG, Parton TA, King LM, Smith BJ, Lang V, Stephens PE. F (ab′)2 molecules made from Escherichia coli produced Fab′ with hinge sequences conferring increased serum survival in an animal model. J Immunol Methods 1998;217:1-10
-
(1998)
J Immunol Methods
, vol.217
, pp. 1-10
-
-
Humphreys, D.P.1
Vetterlein, O.M.2
Chapman, A.P.3
King, D.J.4
Antoniw, P.5
Suitters, A.J.6
Reeks, D.G.7
Parton, T.A.8
King, L.M.9
Smith, B.J.10
Lang, V.11
Stephens, P.E.12
-
23
-
-
0032771256
-
Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen
-
Maeda F, Nagatsuka Y, Ihara S, Aotsuka S, Ono Y, Inoko H, Takekoshi M. Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen. J Med Virol 1999;58:338-345
-
(1999)
J Med Virol
, vol.58
, pp. 338-345
-
-
Maeda, F.1
Nagatsuka, Y.2
Ihara, S.3
Aotsuka, S.4
Ono, Y.5
Inoko, H.6
Takekoshi, M.7
-
24
-
-
0033152763
-
Bacterial expression and purification of the Fab fragment of a monoclonal antibody specific for the low-density lipoprotein receptor-binding site of human apolipoprotein E
-
Raffai R, Vukmirica J, Weisgraber KH, Rassart E, Innerarity TL, Milne R. Bacterial expression and purification of the Fab fragment of a monoclonal antibody specific for the low-density lipoprotein receptor-binding site of human apolipoprotein E. Protein Expr Purif 1999;16:84-90
-
(1999)
Protein Expr Purif
, vol.16
, pp. 84-90
-
-
Raffai, R.1
Vukmirica, J.2
Weisgraber, K.H.3
Rassart, E.4
Innerarity, T.L.5
Milne, R.6
|